Leonardo Iaccarino, PhD

Title(s)Assistant Researcher, Neurology
SchoolSchool of Medicine
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. rPOP: Robust PET-only processing of community acquired heterogeneous amyloid-PET data. Neuroimage. 2021 Dec 07; 246:118775. Iaccarino L, La Joie R, Koeppe R, Siegel BA, Hillner BE, Gatsonis C, Whitmer RA, Whitmer RA, Carrillo MC, Apgar C, Camacho MR, Nosheny R, Rabinovici GD, Alzheimer's Disease Neuroimaging Initiative. PMID: 34890793.
      View in: PubMed   Mentions:
    2. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. Lancet Neurol. 2021 09; 20(9):739-752. Thijssen EH, La Joie R, Strom A, Fonseca C, Iaccarino L, Wolf A, Spina S, Allen IE, Cobigo Y, Heuer H, VandeVrede L, Proctor NK, Lago AL, Baker S, Sivasankaran R, Kieloch A, Kinhikar A, Yu L, Valentin MA, Jeromin A, Zetterberg H, Hansson O, Mattsson-Carlgren N, Graham D, Blennow K, Kramer JH, Grinberg LT, Seeley WW, Rosen H, Boeve BF, Miller BL, Teunissen CE, Rabinovici GD, Rojas JC, Dage JL, Boxer AL, Advancing Research and Treatment for Frontotemporal Lobar Degeneration investigators. PMID: 34418401.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    3. Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial. JAMA Netw Open. 2021 Sep 01; 4(9):e2125584. Ljubenkov PA, Edwards L, Iaccarino L, La Joie R, Rojas JC, Koestler M, Harris B, Boeve BF, Borroni B, van Swieten JC, Grossman M, Pasquier F, Frisoni GB, Mummery CJ, Vandenberghe R, Le Ber I, Hannequin D, McGinnis SM, Auriacombe S, Onofrj M, Goodman IJ, Riordan HJ, Wisniewski G, Hesterman J, Marek K, Haynes BA, Patzke H, Koenig G, Hilt D, Moebius H, Boxer AL. PMID: 34559230; PMCID: PMC8463943.
      View in: PubMed   Mentions:    Fields:    
    4. Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease. Brain. 2021 Aug 09. Strom A, Iaccarino L, Edwards L, Lesman-Segev OH, Soleimani-Meigooni DN, Pham J, Baker SL, Landau S, Jagust WJ, Miller BL, Rosen HJ, Gorno-Tempini ML, Rabinovici GD, La Joie R, the Alzheimer’s Disease Neuroimaging Initiative. PMID: 34373896.
      View in: PubMed   Mentions:    Fields:    
    5. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging. JAMA Neurol. 2021 Aug 01; 78(8):961-971. Ossenkoppele R, Smith R, Mattsson-Carlgren N, Groot C, Leuzy A, Strandberg O, Palmqvist S, Olsson T, Jögi J, Stormrud E, Cho H, Ryu YH, Choi JY, Boxer AL, Gorno-Tempini ML, Miller BL, Soleimani-Meigooni D, Iaccarino L, La Joie R, Baker S, Borroni E, Klein G, Pontecorvo MJ, Devous MD, Jagust WJ, Lyoo CH, Rabinovici GD, Hansson O. PMID: 34180956; PMCID: PMC8240013.
      View in: PubMed   Mentions: 3     Fields:    
    6. The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology. Alzheimers Dement. 2021 May 21. Apostolova LG, Aisen P, Eloyan A, Fagan A, Fargo KN, Foroud T, Gatsonis C, Grinberg LT, Jack CR, Kramer J, Koeppe R, Kukull WA, Murray ME, Nudelman K, Rumbaugh M, Toga A, Vemuri P, Trullinger A, Iaccarino L, Day GS, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Rogalski E, Salloway S, Wolk DA, Wingo TS, Carrillo MC, Dickerson BC, Rabinovici GD, LEADS Consortium. PMID: 34018654.
      View in: PubMed   Mentions:    Fields:    
    7. Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females. Neurobiol Aging. 2021 09; 105:86-98. Edwards L, La Joie R, Iaccarino L, Strom A, Baker SL, Casaletto KB, Cobigo Y, Grant H, Kim M, Kramer JH, Mellinger TJ, Pham J, Possin KL, Rosen HJ, Soleimani-Meigooni DN, Wolf A, Miller BL, Rabinovici GD. PMID: 34049062.
      View in: PubMed   Mentions:    Fields:    
    8. Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2021 Apr 13. Singleton E, Hansson O, Pijnenburg YAL, La Joie R, Mantyh WG, Tideman P, Stomrud E, Leuzy A, Johansson M, Strandberg O, Smith R, Berendrecht E, Miller BL, Iaccarino L, Edwards L, Strom A, Wolters EE, Coomans E, Visser D, Golla SSV, Tuncel H, Bouwman F, Van Swieten JC, Papma JM, van Berckel B, Scheltens P, Dijkstra AA, Rabinovici GD, Ossenkoppele R. PMID: 33850001; PMCID: PMC8292599.
      View in: PubMed   Mentions:    Fields:    
    9. Crossed cerebellar diaschisis on 18F-FDG PET: Frequency across neurodegenerative syndromes and association with 11C-PIB and 18F-Flortaucipir. J Cereb Blood Flow Metab. 2021 Sep; 41(9):2329-2343. Provost K, La Joie R, Strom A, Iaccarino L, Edwards L, Mellinger TJ, Pham J, Baker SL, Miller BL, Jagust WJ, Rabinovici GD. PMID: 33691512; PMCID: PMC8393295.
      View in: PubMed   Mentions:    Fields:    
    10. Detecting Alzheimer's disease biomarkers with a brief tablet-based cognitive battery: sensitivity to Aβ and tau PET. Alzheimers Res Ther. 2021 02 08; 13(1):36. Tsoy E, Strom A, Iaccarino L, Erlhoff SJ, Goode CA, Rodriguez AM, Rabinovici GD, Miller BL, Kramer JH, Rankin KP, La Joie R, Possin KL. PMID: 33557905; PMCID: PMC7871372.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Association Between Ambient Air Pollution and Amyloid Positron Emission Tomography Positivity in Older Adults With Cognitive Impairment. JAMA Neurol. 2021 Feb 01; 78(2):197-207. Iaccarino L, La Joie R, Lesman-Segev OH, Lee E, Hanna L, Allen IE, Hillner BE, Siegel BA, Whitmer RA, Whitmer RA, Carrillo MC, Gatsonis C, Rabinovici GD. PMID: 33252608; PMCID: PMC7879238.
      View in: PubMed   Mentions: 4     Fields:    
    12. Association of remote mild traumatic brain injury with cortical amyloid burden in clinically normal older adults. Brain Imaging Behav. 2021 Oct; 15(5):2417-2425. Asken BM, Mantyh WG, La Joie R, Strom A, Casaletto KB, Staffaroni AM, Apple AC, Lindbergh CA, Iaccarino L, You M, Grant H, Fonseca C, Windon C, Younes K, Tanner J, Rabinovici GD, Kramer JH, Gardner RC. PMID: 33432536; PMCID: PMC8272743.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts. Eur J Nucl Med Mol Imaging. 2021 07; 48(7):2259-2271. Provost K, Iaccarino L, Soleimani-Meigooni DN, Baker S, Edwards L, Eichenlaub U, Hansson O, Jagust W, Janabi M, La Joie R, Lesman-Segev O, Mellinger TJ, Miller BL, Ossenkoppele R, Pham J, Smith R, Sonni I, Strom A, Mattsson-Carlgren N, Rabinovici GD, Alzheimer’s Disease Neuroimaging Initiative (ADNI). PMID: 33398408; PMCID: PMC8178158.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Spatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer's Disease Continuum. Cereb Cortex. 2021 01 01; 31(1):1-14. Iaccarino L, La Joie R, Edwards L, Strom A, Schonhaut DR, Ossenkoppele R, Pham J, Mellinger T, Janabi M, Baker SL, Soleimani-Meigooni D, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD. PMID: 32808011; PMCID: PMC7727356.
      View in: PubMed   Mentions: 1     Fields:    
    15. Glucose metabolism mainly reflects local atrophy and tau pathology at symptomatic stages of Alzheimer’s disease. Alzheimer's & Dementia. 2020 Dec 7; 16(S4). Strom SA, Iaccarino IL, Edwards EL, Lesman-Segev LO, Soleimani-Meigooni SD, Jagust JW, Miller MB, Rabinovici RG, La Joie LR. .
      View in: Publisher Site   Mentions:
    16. How ‘atypical’ is the neuroimaging signature of Alzheimer’s atypical variants? MRI and PET imaging of posterior cortical atrophy and logopenic variant of primary progressive aphasia. Alzheimer's & Dementia. 2020 Dec 7; 16(S6). La Joie LR, Damasceno DP, Visani VA, Iaccarino IL, Strom SA, Edwards EL, Gorno-Tempini GM, Jagust JW, Miller MB, Raj RA, Rabinovici RG. .
      View in: Publisher Site   Mentions:
    17. Colocalization of atrophy and tau improves AI classification of Alzheimer phenotypical variants. Alzheimer's & Dementia. 2020 Dec 7; 16(S1). Damasceno DP, La Joie LR, Maia MP, Visani VA, Iaccarino IL, Strom SA, Edwards EL, Tempini TM, Jagust JW, Miller MB, Rabinovici RG, Raj RA. .
      View in: Publisher Site   Mentions:
    18. [18F]Flortaucipir PET to autopsy pathology comparisons in Alzheimer’s disease and other neurodegenerative diseases. Alzheimer's & Dementia. 2020 Dec 7; 16(S4). Soleimani-Meigooni SD, Iaccarino IL, La Joie LR, Baker BS, Bourakova BV, Boxer BA, Edwards EL, Eser ER, Tempini TM, Jagust JW, Janabi JM, kramer kJ, Lesman-Segev LO, Mellinger MT, Miller MB, Pham PJ, Rosen RH, Spina SS, Seeley SW, Strom SA, Grinberg GL, Rabinovici RG. .
      View in: Publisher Site   Mentions:
    19. Comparison of 18F-Flortaucipir visual assessment, SUVR quantification and CSF pTau for defining T-status in the AT(N) framework. Alzheimer's & Dementia. 2020 Dec 7; 16(S4). Provost PK, Iaccarino IL, Soleimani-Meigooni SD, Lesman-Segev LO, Joie JR, Mattsson MN, Hansson HO, Eichenlaub EU, Edwards EL, Strom SA, Pham PJ, Mellinger MT, Janabi JM, Baker BS, Jagust JW, Rabinovici RG, ADNI A. .
      View in: Publisher Site   Mentions:
    20. Associations between ambient air pollution and Alzheimer pathologic change in humans: A secondary analysis of IDEAS study data. Alzheimer's & Dementia. 2020 Dec 7; 16(S5). Iaccarino IL, La Joie LR, Lesman-Segev LO, Lee LE, Hanna HL, Gatsonis GC, Rabinovici RG. .
      View in: Publisher Site   Mentions:
    21. Diagnostic Accuracy of Amyloid versus 18 F-Fluorodeoxyglucose Positron Emission Tomography in Autopsy-Confirmed Dementia. Ann Neurol. 2021 02; 89(2):389-401. Lesman-Segev OH, La Joie R, Iaccarino L, Lobach I, Rosen HJ, Seo SW, Janabi M, Baker SL, Edwards L, Pham J, Olichney J, Boxer A, Huang E, Gorno-Tempini M, DeCarli C, Hepker M, Hwang JL, Miller BL, Spina S, Grinberg LT, Seeley WW, Jagust WJ, Rabinovici GD. PMID: 33219525; PMCID: PMC7856004.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases. Brain. 2020 12 05; 143(11):3477-3494. Soleimani-Meigooni DN, Iaccarino L, La Joie R, Baker S, Bourakova V, Boxer AL, Edwards L, Eser R, Gorno-Tempini ML, Jagust WJ, Janabi M, Kramer JH, Lesman-Segev OH, Mellinger T, Miller BL, Pham J, Rosen HJ, Spina S, Seeley WW, Strom A, Grinberg LT, Rabinovici GD. PMID: 33141172; PMCID: PMC7719031.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    23. Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET. Neurology. 2021 02 02; 96(5):e650-e661. La Joie R, Visani AV, Lesman-Segev OH, Baker SL, Edwards L, Iaccarino L, Soleimani-Meigooni DN, Mellinger T, Janabi M, Miller ZA, Perry DC, Pham J, Strom A, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD. PMID: 33262228; PMCID: PMC7884991.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    24. Evaluation of a visual interpretation method for tau-PET with 18F-flortaucipir. Alzheimers Dement (Amst). 2020; 12(1):e12133. Sonni I, Lesman Segev OH, Baker SL, Iaccarino L, Korman D, Rabinovici GD, Jagust WJ, Landau SM, La Joie R, Alzheimer's Disease Neuroimaging Initiative. PMID: 33313377; PMCID: PMC7699207.
      View in: PubMed   Mentions: 1  
    25. The impact of demographic, clinical, genetic, and imaging variables on tau PET status. Eur J Nucl Med Mol Imaging. 2021 07; 48(7):2245-2258. Ossenkoppele R, Leuzy A, Cho H, Sudre CH, Strandberg O, Smith R, Palmqvist S, Mattsson-Carlgren N, Olsson T, Jögi J, Stormrud E, Ryu YH, Choi JY, Alzheimer’s Disease Neuroimaging Initiative, PREVENT-AD research group, Boxer AL, Gorno-Tempini ML, Miller BL, Soleimani-Meigooni D, Iaccarino L, La Joie R, Borroni E, Klein G, Pontecorvo MJ, Devous MD, Villeneuve S, Lyoo CH, Rabinovici GD, Hansson O. PMID: 33215319; PMCID: PMC8131404.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    26. Sex-related differences in the relationship between β-amyloid and cognitive trajectories in older adults. Neuropsychology. 2020 Nov; 34(8):835-850. Lindbergh CA, Casaletto KB, Staffaroni AM, La Joie R, Iaccarino L, Edwards L, Tsoy E, Elahi F, Walters SM, Cotter D, You M, Apple AC, Asken B, Neuhaus J, Rexach JE, Wojta KJ, Rabinovici G, Kramer JH, Hillblom Aging Network. PMID: 33030915; PMCID: PMC7839841.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    27. Diagnostic Assessment in Primary Progressive Aphasia: An Illustrative Case Example. Am J Speech Lang Pathol. 2020 11 12; 29(4):1833-1849. Europa E, Iaccarino L, Perry DC, Weis E, Welch AE, Rabinovici GD, Miller BL, Gorno-Tempini ML, Henry ML. PMID: 32910678.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. 11 C-PK11195 PET-based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2020 09; 7(9):1513-1523. Tondo G, Iaccarino L, Cerami C, Vanoli GE, Presotto L, Masiello V, Coliva A, Salvi F, Bartolomei I, Mosca L, Lunetta C, Perani D. PMID: 32762033; PMCID: PMC7480909.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    29. Longitudinal structural and metabolic changes in frontotemporal dementia. Neurology. 2020 07 14; 95(2):e140-e154. Bejanin A, Tammewar G, Marx G, Cobigo Y, Iaccarino L, Kornak J, Staffaroni AM, Dickerson BC, Boeve BF, Knopman DS, Gorno-Tempini M, Miller BL, Jagust WJ, Boxer AL, Rosen HJ, Rabinovici GD. PMID: 32591470; PMCID: PMC7455324.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    30. The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer's disease. Alzheimers Res Ther. 2020 04 30; 12(1):50. Tondo G, Iaccarino L, Caminiti SP, Presotto L, Santangelo R, Iannaccone S, Magnani G, Perani D. PMID: 32354345; PMCID: PMC7193377.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    31. Tau Positron Emission Tomographic Findings in a Former US Football Player With Pathologically Confirmed Chronic Traumatic Encephalopathy. JAMA Neurol. 2020 04 01; 77(4):517-521. Mantyh WG, Spina S, Lee A, Iaccarino L, Soleimani-Meigooni D, Tsoy E, Mellinger TJ, Grant H, Vandevrede L, La Joie R, Lesman-Segev O, Gaus S, Possin KL, Grinberg LT, Miller BL, Seeley WW, Rabinovici GD. PMID: 31904765; PMCID: PMC6990867.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    32. Neurophysiological signatures in Alzheimer's disease are distinctly associated with TAU, amyloid-β accumulation, and cognitive decline. Sci Transl Med. 2020 03 11; 12(534). Ranasinghe KG, Cha J, Iaccarino L, Hinkley LB, Beagle AJ, Pham J, Jagust WJ, Miller BL, Rankin KP, Rabinovici GD, Vossel KA, Nagarajan SS. PMID: 32161102; PMCID: PMC7138514.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    33. Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration. Nat Med. 2020 03; 26(3):387-397. Thijssen EH, La Joie R, Wolf A, Strom A, Wang P, Iaccarino L, Bourakova V, Cobigo Y, Heuer H, Spina S, VandeVrede L, Chai X, Proctor NK, Airey DC, Shcherbinin S, Duggan Evans C, Sims JR, Zetterberg H, Blennow K, Karydas AM, Teunissen CE, Kramer JH, Grinberg LT, Seeley WW, Rosen H, Boeve BF, Miller BL, Rabinovici GD, Dage JL, Rojas JC, Boxer AL, Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) investigators. PMID: 32123386; PMCID: PMC7101073.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansCells
    34. In vivo MRI Structural and PET Metabolic Connectivity Study of Dopamine Pathways in Alzheimer's Disease. J Alzheimers Dis. 2020; 75(3):1003-1016. Iaccarino L, Sala A, Caminiti SP, Presotto L, Perani D, Alzheimer’s Disease Neuroimaging Initiative. PMID: 32390614.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    35. Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET. Sci Transl Med. 2020 01 01; 12(524). La Joie R, Visani AV, Baker SL, Brown JA, Bourakova V, Cha J, Chaudhary K, Edwards L, Iaccarino L, Janabi M, Lesman-Segev OH, Miller ZA, Perry DC, O'Neil JP, Pham J, Rojas JC, Rosen HJ, Seeley WW, Tsai RM, Miller BL, Jagust WJ, Rabinovici GD. PMID: 31894103; PMCID: PMC7035952.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    36. Vulnerability of multiple large-scale brain networks in dementia with Lewy bodies. Hum Brain Mapp. 2019 10 15; 40(15):4537-4550. Sala A, Caminiti SP, Iaccarino L, Beretta L, Iannaccone S, Magnani G, Padovani A, Ferini-Strambi L, Perani D. PMID: 31322307; PMCID: PMC6917031.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    37. PREDICTORS OF ß-AMYLOID POSITIVITY IN COGNITIVELY IMPAIRED PATIENTS: DATA FROM THE IMAGING DEMENTIA — EVIDENCE FOR AMYLOID SCANNING (IDEAS) STUDY. Alzheimer's & Dementia. 2019 Jul 1; 15(7):p21-p22. Lesman-Segev LO, Hanna HL, La Joie LR, Iaccarino IL, Siegel SB, Hillner HB, Whitmer WR, Carrillo CM, Apgar AC, Olson OC, Edwards EL, Chaudhary CK, Gatsonis GC, Rabinovici RG. .
      View in: Publisher Site   Mentions:
    38. PREDICTORS OF ß-AMYLOID POSITIVITY IN COGNITIVELY IMPAIRED PATIENTS: DATA FROM THE IMAGING DEMENTIA – EVIDENCE FOR AMYLOID SCANNING (IDEAS) STUDY. Alzheimer's & Dementia. 2019 Jul 1; 15(7):p540-p541. Lesman-Segev LO, Hanna HL, La Joie LR, Iaccarino IL, Siegel SB, Hillner HB, Whitmer WR, Carrillo CM, Apgar AC, Olson OC, Edwards EL, Chaudhary CK, Gatsonis GC, Rabinovici RG. .
      View in: Publisher Site   Mentions:
    39. SPATIAL DISTRIBUTION AND TOPOGRAPHICAL RELATIONSHIPS OF PATHOLOGY AND NEURODEGENERATION IN ALZHEIMER’S DISEASE. Alzheimer's & Dementia. 2019 Jul 1; 15(7):p71-p72. Iaccarino IL, Schonhaut SD, La Joie LR, Ossenkoppele OR, Bejanin BA, Edwards EL, Tammewar TG, Pham PJ, Chaudhary CK, Janabi JM, Baker BS, Miller MB, Jagust JW, Rabinovici RG. .
      View in: Publisher Site   Mentions:
    40. CEREBROSPINAL FLUID BIOMARKERS FOR AMYLOID AND TAU USING FULLY AUTOMATED ASSAYS: ASSOCIATIONS WITH NEUROPATHOLOGY. Alzheimer's & Dementia. 2019 Jul 1; 15(7):p1521. Mattsson MN, Grinberg GL, Jonsson JM, Seeley SW, Spina SS, Janelidze JS, Rosen RH, Boxer BA, La Joie LR, Lesman-Segev LO, Iaccarino IL, Kollmorgen KG, Eichenlaub EU, Miller MB, Hansson HO, Rabinovici RG. .
      View in: Publisher Site   Mentions:
    41. SPATIAL DISTRIBUTION AND TOPOGRAPHICAL RELATIONSHIPS OF PATHOLOGY AND NEURODEGENERATION IN ALZHEIMER’S DISEASE. Alzheimer's & Dementia. 2019 Jul 1; 15(7):p720-p721. Iaccarino IL, Schonhaut SD, La Joie LR, Ossenkoppele OR, Bejanin BA, Edwards EL, Tammewar TG, Pham PJ, Chaudhary CK, Janabi JM, Baker BS, Miller MB, Jagust JW, Rabinovici RG. .
      View in: Publisher Site   Mentions:
    42. [18F]FLORTAUCIPIR PET AND PATHOLOGY CORRELATIONS IN ALZHEIMER’S DISEASE, NON-ALZHEIMER’S TAUOPATHIES, AND OTHER NEURODEGENERATIVE DISEASES. Alzheimer's & Dementia. 2019 Jul 1; 15(7):p782. Soleimani-Meigooni SD, Iaccarino IL, La Joie LR, Lesman-Segev LO, Bourakova BV, Strom SA, Edwards EL, Baker BS, Janabi JM, Eser ER, Larsen LE, Spina SS, Seeley SW, Grinberg GL, Jagust JW, Rabinovici RG. .
      View in: Publisher Site   Mentions:
    43. ADVANCING CLINICAL AND BIOMARKER RESEARCH IN AD: THE LEAD STUDY. Alzheimer's & Dementia. 2019 Jul 1; 15(7):p383-p384. Apostolova AL, Iaccarino IL, Collins CJ, Aisen AP, Borowski BB, Eloyan EA, Fagan FA, Foroud FT, Gatsonis GC, Jack JC, Kramer KJ, Koeppe KR, Saykin SA, Toga TA, Vemuri VP, Day DG, Graff-Radford GN, Honig HL, Jones JD, Masdeu MJ, Mendez MM, Onyike OC, Rogalski RE, Salloway SS, Wolk WD, Wingo WT, Rabinovici RG, Dickerson DB, Carrillo CM. .
      View in: Publisher Site   Mentions:
    44. A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies. Alzheimers Dement. 2019 08; 15(8):1081-1103. Perani D, Iaccarino L, Lammertsma AA, Windhorst AD, Edison P, Boellaard R, Hansson O, Nordberg A, Jacobs AH, IMBI Project. PMID: 31230910.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    45. Predicting long-term clinical stability in amyloid-positive subjects by FDG-PET. Ann Clin Transl Neurol. 2019 Jun; 6(6):1113-1120. Iaccarino L, Sala A, Perani D, Alzheimer's Disease Neuroimaging Initiative. PMID: 31211176; PMCID: PMC6562030.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    46. Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain. Neuroimage Clin. 2019; 23:101848. Ossenkoppele R, Iaccarino L, Schonhaut DR, Brown JA, La Joie R, O'Neil JP, Janabi M, Baker SL, Kramer JH, Gorno-Tempini ML, Miller BL, Rosen HJ, Seeley WW, Jagust WJ, Rabinovici GD. PMID: 31077982; PMCID: PMC6510968.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    47. Application of advanced brain positron emission tomography-based molecular imaging for a biological framework in neurodegenerative proteinopathies. Alzheimers Dement (Amst). 2019 Dec; 11:327-332. Perani D, Iaccarino L, Jacobs AH, IMBI Brain Imaging Working Group. PMID: 31080871; PMCID: PMC6505113.
      View in: PubMed   Mentions: 2  
    48. Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria. Alzheimers Res Ther. 2019 02 23; 11(1):20. Caminiti SP, Sala A, Iaccarino L, Beretta L, Pilotto A, Gianolli L, Iannaccone S, Magnani G, Padovani A, Ferini-Strambi L, Perani D. PMID: 30797240; PMCID: PMC6387558.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    49. Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis. Eur J Nucl Med Mol Imaging. 2019 May; 46(5):1117-1131. Sala A, Iaccarino L, Fania P, Vanoli EG, Fallanca F, Pagnini C, Cerami C, Calvo A, Canosa A, Pagani M, Chiò A, Cistaro A, Perani D. PMID: 30617963.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    50. Prefrontal Cortical Stimulation in Tourette Disorder: Proof-of-concept Clinical and Neuroimaging Study. Mov Disord Clin Pract. 2018 Sep-Oct; 5(5):499-505. Perani D, Lalli S, Iaccarino L, Alongi P, Gambini O, Franzini A, Albanese A. PMID: 30515438; PMCID: PMC6207124.
      View in: PubMed   Mentions: 1  
    51. Low-dose CT for the spatial normalization of PET images: A validation procedure for amyloid-PET semi-quantification. Neuroimage Clin. 2018; 20:153-160. Presotto L, Iaccarino L, Sala A, Vanoli EG, Muscio C, Nigri A, Bruzzone MG, Tagliavini F, Gianolli L, Perani D, Bettinardi V. PMID: 30094164; PMCID: PMC6072675.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    52. The brain metabolic signature of visual hallucinations in dementia with Lewy bodies. Cortex. 2018 11; 108:13-24. Iaccarino L, Sala A, Caminiti SP, Santangelo R, Iannaccone S, Magnani G, Perani D. PMID: 30098477.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    53. LONG-TERM CLINICAL STABILITY IN AMYLOID-POSITIVE SUBJECTS IS PREDICTED BY NEGATIVE FDG-PET SCAN. Alzheimer's & Dementia. 2018 Jul 1; 14(7):p1409. Iaccarino IL, Sala SA, Perani PD. .
      View in: Publisher Site   Mentions:
    54. Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia. JAMA Neurol. 2018 03 01; 75(3):342-352. Santos-Santos MA, Rabinovici GD, Iaccarino L, Ayakta N, Tammewar G, Lobach I, Henry ML, Hubbard I, Mandelli ML, Spinelli E, Miller ZA, Pressman PS, O'Neil JP, Ghosh P, Lazaris A, Meyer M, Watson C, Yoon SJ, Rosen HJ, Grinberg L, Seeley WW, Miller BL, Jagust WJ, Gorno-Tempini ML. PMID: 29309493; PMCID: PMC5885868.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    55. 18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis. J Neuroinflammation. 2018 Feb 05; 15(1):33. Belloli S, Zanotti L, Murtaj V, Mazzon C, Di Grigoli G, Monterisi C, Masiello V, Iaccarino L, Cappelli A, Poliani PL, Politi LS, Moresco RM. PMID: 29402285; PMCID: PMC5800080.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    56. PET Evaluation of Late Cerebral Effect in Advanced Radiation Therapy Techniques for Cranial Base Tumors. Curr Radiopharm. 2018; 11(2):86-91. Alongi P, Iaccarino L, Losa M, Del Vecchio A, Gerevini S, Plebani V, Di Muzio N, Mortini P, Gianolli L, Perani D. PMID: 29804540.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    57. An in vivo 11C-PK PET study of microglia activation in Fatal Familial Insomnia. Ann Clin Transl Neurol. 2018 01; 5(1):11-18. Iaccarino L, Presotto L, Bettinardi V, Gianolli L, Roiter I, Capellari S, Parchi P, Cortelli P, Perani D. PMID: 29376088; PMCID: PMC5771322.
      View in: PubMed   Mentions: 3     Fields:    
    58. The emerging role of PET imaging in dementia. F1000Res. 2017; 6:1830. Iaccarino L, Sala A, Caminiti SP, Perani D. PMID: 29071066; PMCID: PMC5639932.
      View in: PubMed   Mentions: 13     Fields:    
    59. Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease. Neuroimage Clin. 2018; 17:452-464. Iaccarino L, Tammewar G, Ayakta N, Baker SL, Bejanin A, Boxer AL, Gorno-Tempini ML, Janabi M, Kramer JH, Lazaris A, Lockhart SN, Miller BL, Miller ZA, O'Neil JP, Ossenkoppele R, Rosen HJ, Schonhaut DR, Jagust WJ, Rabinovici GD. PMID: 29159058; PMCID: PMC5684433.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    60. CONCORDANCE IN SPATIAL EXTENT AND AMOUNT OF BRAIN MICROGLIA ACTIVATION WITH GLUCOSE HYPOMETABOLISM IN EARLY ONSET ALZHEIMER’S DISEASE. Alzheimer's & Dementia. 2017 Jul 1; 13(7):p766. Iaccarino IL, Presotto PL, Cerami CC, Bettinardi BV, Iannaccone IS, Magnani MG, Perani PD. .
      View in: Publisher Site   Mentions:
    61. Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging. Int J Mol Sci. 2017 May 05; 18(5). Cerami C, Iaccarino L, Perani D. PMID: 28475165; PMCID: PMC5454906.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    62. An In Vivo 11C-(R)-PK11195 PET and In Vitro Pathology Study of Microglia Activation in Creutzfeldt-Jakob Disease. Mol Neurobiol. 2018 Apr; 55(4):2856-2868. Iaccarino L, Moresco RM, Presotto L, Bugiani O, Iannaccone S, Giaccone G, Tagliavini F, Perani D. PMID: 28455699.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    63. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting. J Alzheimers Dis. 2017; 59(2):603-614. Iaccarino L, Chiotis K, Alongi P, Almkvist O, Wall A, Cerami C, Bettinardi V, Gianolli L, Nordberg A, Perani D. PMID: 28671117.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    64. Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer's disease. Hum Brain Mapp. 2016 12; 37(12):4234-4247. Ballarini T, Iaccarino L, Magnani G, Ayakta N, Miller BL, Jagust WJ, Gorno-Tempini ML, Rabinovici GD, Perani D. PMID: 27412866; PMCID: PMC5521254.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    65. TAU-PET PATTERNS OVERLAP AND EXCEED HYPOMETABOLISM IN ALZHEIMER'S DISEASE. Alzheimer's & Dementia. 2016 Jul 1; 12(7):p545-p547. Schonhaut SD, Ossenkoppele OR, Bejanin BA, Iaccarino IL, Baker BS, Lazaris LA, Cantwell CA, Tammewar TG, Ayakta AN, Lockhart LS, Scholl SM, O'Neil OJ, Miller MB, Jagust JW, Rabinovici RG. .
      View in: Publisher Site   Mentions:
    66. TAU-PET PATTERNS OVERLAP AND EXCEED HYPOMETABOLISM IN ALZHEIMER'S DISEASE. Alzheimer's & Dementia. 2016 Jul 1; 12(7):p132-p133. Schonhaut SD, Ossenkoppele OR, Bejanin BA, Iaccarino IL, Baker BS, Lazaris LA, Cantwell CA, Tammewar TG, Ayakta AN, Lockhart LS, Scholl SM, O'Neil OJ, Miller MB, Jagust JW, Rabinovici RG. .
      View in: Publisher Site   Mentions:
    67. LONGITUDINAL BRAIN METABOLIC CHANGES IN FRONTOTEMPORAL LOBAR DEGENERATION CONTINUUM. Alzheimer's & Dementia. 2016 Jul 1; 12(7):p189-p191. Bejanin BA, Ayakta AN, Schonhaut SD, Marx MG, Tammewar TG, Cobigo CY, McKenna MF, Iaccarino IL, Gorno-Tempini GM, Miller MB, Jagust JW, Rosen RH, Rabinovici RG. .
      View in: Publisher Site   Mentions:
    68. LONGITUDINAL BRAIN METABOLIC CHANGES IN FRONTOTEMPORAL LOBAR DEGENERATION CONTINUUM. Alzheimer's & Dementia. 2016 Jul 1; 12(7):p64-p66. Bejanin BA, Ayakta AN, Schonhaut SD, Marx MG, Tammewar TG, Cobigo CY, McKenna MF, Iaccarino IL, Gorno-Tempini GM, Miller MB, Jagust JW, Rosen RH, Rabinovici RG. .
      View in: Publisher Site   Mentions:
    69. Severe Brain Metabolic Decreases Associated with REM Sleep Behavior Disorder in Dementia with Lewy Bodies. J Alzheimers Dis. 2016 04 05; 52(3):989-97. Iaccarino L, Marelli S, Iannaccone S, Magnani G, Ferini-Strambi L, Perani D. PMID: 27060952.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    70. Qualitative patterns at Raven's colored progressive matrices in mild cognitive impairment and Alzheimer's disease. Aging Clin Exp Res. 2016 Jun; 28(3):561-5. Ambra FI, Iavarone A, Ronga B, Chieffi S, Carnevale G, Iaccarino L, Cimminella F, Chiavazzo A, Garofalo E. PMID: 26296535.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    71. The semantic variant of primary progressive aphasia: clinical and neuroimaging evidence in single subjects. PLoS One. 2015; 10(3):e0120197. Iaccarino L, Crespi C, Della Rosa PA, Catricalà E, Guidi L, Marcone A, Tagliavini F, Magnani G, Cappa SF, Perani D. PMID: 25756991; PMCID: PMC4354903.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    72. PET Neuroimaging: Insights on Dystonia and Tourette Syndrome and Potential Applications. Front Neurol. 2014; 5:183. Alongi P, Iaccarino L, Perani D. PMID: 25295029; PMCID: PMC4171987.
      View in: PubMed   Mentions: 5  
    73. Age-related differences in distractor interference on line bisection. Exp Brain Res. 2014 Nov; 232(11):3659-64. Chieffi S, Iavarone A, Iaccarino L, La Marra M, Messina G, De Luca V, Monda M. PMID: 25092273.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    74. The need for “objective measurements” in FDG and amyloid PET neuroimaging. Clinical and Translational Imaging. 2014 Aug 1; 2(4):331-342. Perani PD, Iaccarino IL, Bettinardi BV. .
      View in: Publisher Site   Mentions:
    75. A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis. Biomed Res Int. 2014; 2014:785039. Perani D, Daniela P, Schillaci O, Orazio S, Padovani A, Alessandro P, Nobili FM, Mariano NF, Iaccarino L, Leonardo I, Della Rosa PA, Pasquale Anthony DR, Frisoni G, Giovanni F, Caltagirone C, Carlo C. PMID: 24772437; PMCID: PMC3977528.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    76. Utilization behavior: what is known and what has to be known? Behav Neurol. 2014; 2014:297128. Iaccarino L, Chieffi S, Iavarone A. PMID: 24825954; PMCID: PMC4006616.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    77. Erratum to “A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis”. BioMed Research International. 2014 Jan 1; 2014:1-1. Perani PD, Schillaci SO, Padovani PA, Nobili NF, Iaccarino IL, Della Rosa DP, Frisoni FG, Caltagirone CC. .
      View in: Publisher Site   Mentions:
    Leonardo's Networks
    Concepts (143)
    Derived automatically from this person's publications.
    _
    Co-Authors (55)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _